Galera Therapeutics Inc at Piper Sandler Healthcare Conference Transcript
Good morning. My name is Derek Robertson. (Inaudible) as Specialist at Piper Sandler. My pleasure to introduce Galera Therapeutics, ticker GRTX. Galera is preparing to file the NDA for (inaudible) for the prevention of radiotherapy induced severe oral mucositis by year end, along with a number of other exciting oncology programs. Here to present the company is Dr. Mel Sorensen, President and CEO.
Thank you, Derek. Galera's mission is to transform radiotherapy. I'm going to talk about our technology and give you an update on where things are at.
This slide is just a reminder of the forward-looking statements I'll be making. radiation therapy is a key modality for cancer treatment. Of the 1.9 million new cancers annually in the US, over 50% will receive radiation at some part of their treatment. And there are two forms of radiation therapy, external beam radiation therapy, IMRT or intensity modulated radiation therapy, and stereotactic body radiation
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
